ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 67 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $25,068,111 | +158921.3% | 17,169,939 | +17.1% | 0.03% | +62.5% |
| Q3 2022 | $15,764 | -39.5% | 14,664,936 | -4.3% | 0.02% | -40.7% |
| Q2 2022 | $26,046 | -17.8% | 15,321,346 | -0.4% | 0.03% | +22.7% |
| Q1 2022 | $31,684 | -38.6% | 15,380,538 | +11.8% | 0.02% | -21.4% |
| Q4 2021 | $51,587 | -22.2% | 13,756,352 | +7.3% | 0.03% | -20.0% |
| Q3 2021 | $66,306 | +33.1% | 12,824,980 | +9.6% | 0.04% | +45.8% |
| Q2 2021 | $49,828 | -18.2% | 11,696,919 | +2.0% | 0.02% | -29.4% |
| Q1 2021 | $60,892 | +9.1% | 11,467,517 | +10.7% | 0.03% | +9.7% |
| Q4 2020 | $55,828 | -1.2% | 10,357,780 | +46.3% | 0.03% | -20.5% |
| Q3 2020 | $56,482 | +6.7% | 7,078,063 | +33.8% | 0.04% | -2.5% |
| Q2 2020 | $52,950 | +347.1% | 5,289,669 | +21.5% | 0.04% | +207.7% |
| Q1 2020 | $11,843 | +130.2% | 4,354,023 | +1.6% | 0.01% | +160.0% |
| Q4 2019 | $5,145 | -18.2% | 4,287,545 | +2.9% | 0.01% | -28.6% |
| Q3 2019 | $6,289 | -62.2% | 4,164,807 | +0.5% | 0.01% | -61.1% |
| Q2 2019 | $16,658 | +0.9% | 4,143,840 | +7.9% | 0.02% | 0.0% |
| Q1 2019 | $16,508 | -22.4% | 3,839,190 | +3.8% | 0.02% | -35.7% |
| Q4 2018 | $21,272 | -54.1% | 3,699,521 | +8.2% | 0.03% | -44.0% |
| Q3 2018 | $46,343 | +28.7% | 3,417,627 | +12.7% | 0.05% | +28.2% |
| Q2 2018 | $36,005 | +25.0% | 3,033,261 | +18.2% | 0.04% | +14.7% |
| Q1 2018 | $28,810 | +124.6% | 2,565,409 | +33.6% | 0.03% | +112.5% |
| Q4 2017 | $12,829 | +13.6% | 1,920,593 | +39.2% | 0.02% | +14.3% |
| Q3 2017 | $11,297 | +90.2% | 1,379,304 | +4.2% | 0.01% | +75.0% |
| Q2 2017 | $5,941 | +17.1% | 1,323,308 | +43.7% | 0.01% | +14.3% |
| Q1 2017 | $5,075 | +36.1% | 920,984 | 0.0% | 0.01% | +16.7% |
| Q4 2016 | $3,730 | -42.6% | 920,984 | 0.0% | 0.01% | -40.0% |
| Q3 2016 | $6,493 | +85.4% | 920,984 | +114.3% | 0.01% | +66.7% |
| Q2 2016 | $3,502 | +0.3% | 429,700 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $3,493 | – | 429,700 | – | 0.01% | – |
Download | ||||||